Sign in or register to see full information and data.

Studies / CAVD 413


Study information

Grant Affiliation:Walker: bNabs after Infection and Immunization
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2013-03-11
Study Made Public:2013-10-16


Development of broadly neutralizing antibodies in HIV infection and following immunization


CAVD 413 is an immunogenicity study to evaluate the neutralization activity of monoclonal antibodies isolated from the plasma of Clade B HIV-infected individuals in US and German cohorts.


No Products used in study

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.